Genscript Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-532.83	2,962	-95.48	-226.85	-358.71
Depreciation & Amortization	73.3	75.71	71.88	61.18	45.86
Other Amortization	0.74	1.96	2.17	3.07	1.92
Loss (Gain) From Sale of Assets	0.87	1.19	0.69	0.77	0.91
Asset Writedown & Restructuring Costs	-	45.51	11.66	11.48	-
Loss (Gain) From Sale of Investments	391.56	-0.19	-2.43	3.64	-0.53
Loss (Gain) on Equity Investments	320.38	39.07	1.38	0.03	-
Stock-Based Compensation	14.79	76.52	60.59	65.15	39.69
Provision & Write-off of Bad Debts	-1.33	6.56	4.78	1.15	0.93
Other Operating Activities	59.87	-3,020	264.61	-204.38	-9.51
Change in Accounts Receivable	-16.49	95.46	-116.99	38.07	1.57
Change in Inventory	-8.58	-10.53	-3.93	-19.53	-15.14
Change in Accounts Payable	6.95	15.99	-37.03	25.58	8.07
Change in Unearned Revenue	1.98	-35.75	100.77	6.76	3.54
Change in Other Net Operating Assets	14.31	20.28	-29.74	113.59	144.6
Operating Cash Flow	325.52	75.65	-286.91	-120.29	-136.79
Operating Cash Flow Growth	330.32%	-	-	-	-
Capital Expenditures	-82.13	-195.79	-252.45	-216.11	-133.04
Sale of Property, Plant & Equipment	0.37	0.24	0.24	0.09	0.27
Sale (Purchase) of Intangibles	-1.76	-1.24	-4.05	-2.27	-4.35
Investment in Securities	-83.14	-806	-101.72	-219.75	-82.44
Other Investing Activities	-5.29	-453.57	0.25	-5.25	7.02
Investing Cash Flow	-171.95	-1,456	-357.73	-443.3	-212.55
Long-Term Debt Issued	219.09	102.61	74.39	33.06	26.04
Long-Term Debt Repaid	-142.34	-67.74	-34.06	-7.39	-74.94
Total Debt Repaid	-142.34	-67.74	-34.06	-7.39	-74.94
Net Debt Issued (Repaid)	76.74	34.86	40.33	25.67	-48.89
Issuance of Common Stock	6.02	13.49	17.65	228.13	951.23
Other Financing Activities	-2.51	18.17	1,010	165.52	-0.19
Financing Cash Flow	-144.89	66.52	1,068	419.32	902.14
Foreign Exchange Rate Adjustments	1.82	-0.22	-1.22	-12.7	-0.89
Net Cash Flow	10.5	-1,314	422.4	-156.97	551.91
Free Cash Flow	243.39	-120.14	-539.36	-336.41	-269.83
Free Cash Flow Margin	25.36%	-20.21%	-96.23%	-53.76%	-55.06%
Free Cash Flow Per Share	0.11	-0.06	-0.26	-0.16	-0.13
Cash Interest Paid	11.54	4.68	3.19	2.04	1.58
Cash Income Tax Paid	29.24	16.6	2.66	-0.66	0.71
Levered Free Cash Flow	-67.82	425.25	-305.28	-342.98	-176.43
Unlevered Free Cash Flow	-57.01	430.27	-301.7	-334.69	-174.95
Change in Working Capital	-1.82	85.44	-86.91	164.47	142.65

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.